Remarkably, PLK4 expression varied significantly across tumor types, with the highest levels observed in neuroblastoma, followed by ganglioneuroblastoma and ganglioneuroma (Figure 5A). The gene discussed is PLK4; the disease is ganglioneuroblastoma.